184 related articles for article (PubMed ID: 7451142)
1. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
Bolling R; Meyer-Hamme S; Schauder S
Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
[TBL] [Abstract][Full Text] [Related]
2. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
Carmo-Pereira J; Oliveira Costa F; Pimentel P
Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
[No Abstract] [Full Text] [Related]
3. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
Samson MK; Baker LH; Izbicki RM; Ratanatharathorn V
Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223
[TBL] [Abstract][Full Text] [Related]
4. [Phototoxic dermatitis caused by DTIC-treatment].
Kunze J; Roeber H; Kollakowski M
Z Hautkr; 1980 Jan; 55(2):100-1. PubMed ID: 7405333
[No Abstract] [Full Text] [Related]
5. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
Rudolf Z; Plesnicar S
Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
[TBL] [Abstract][Full Text] [Related]
6. [Budd-Chiari syndrome following dacarbazine therapy of malignant melanoma--an avoidable complication?].
Leyh F; Winzer M; Weber M; Hypa F
Z Hautkr; 1985 Jun; 60(12):961-72. PubMed ID: 4024678
[TBL] [Abstract][Full Text] [Related]
7. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
Rudolf Z; Strojan P
Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
[TBL] [Abstract][Full Text] [Related]
8. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
[TBL] [Abstract][Full Text] [Related]
9. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule.
Pritchard KI; Quirt IC; Cowan DH; Osoba D; Kutas GJ
Cancer Treat Rep; 1980; 64(10-11):1123-6. PubMed ID: 7459898
[TBL] [Abstract][Full Text] [Related]
10. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
[No Abstract] [Full Text] [Related]
11. Dacarbazine-induced photosensitivity reaction.
Yung CW; Winston EM; Lorincz AL
J Am Acad Dermatol; 1981 May; 4(5):541-3. PubMed ID: 7240460
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
[TBL] [Abstract][Full Text] [Related]
13. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
[TBL] [Abstract][Full Text] [Related]
14. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.
Samson MK; Baker LH; Cummings G; Talley RW; McDonald B; Bhathena DB
Cancer Treat Rep; 1982 Feb; 66(2):371-3. PubMed ID: 6459845
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of metastatic malignant melanoma (author's transl)].
Kühböck J; Pehamberger H; Mach K; Diem E; Kokoschka EM; Pötzi P
Wien Klin Wochenschr; 1978 Dec; 90(24):856-8. PubMed ID: 84441
[TBL] [Abstract][Full Text] [Related]
17. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
18. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
Carbone PP; Costello W
Cancer Treat Rep; 1976 Feb; 60(2):193-8. PubMed ID: 769973
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of malignant melanoma using DTIC].
Zaumseil RP; Fiedler H; Lübbe D
Dermatol Monatsschr; 1977 Nov; 163(11):905-14. PubMed ID: 590586
[No Abstract] [Full Text] [Related]
20. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]